Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ornstein

Showing results (211-220 of 233) with videos related to

Pageof 24
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivoA Bond, N M Jones, C A Hicks, et al.
Journal of Medicinal Chemistry|July 21, 1998
Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonistsH Zarrinmayeh, A M Nunes, P L Ornstein, et al.
Cephalalgia : an International Journal of Headache|June 16, 2004
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineC N Sang, N M Ramadan, R G Wallihan, et al.
Nature Neuroscience|June 25, 2002
Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizuresIlse Smolders, Zuner A Bortolotto, Vernon R J Clarke, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2017
Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effectsJ M Witkin, J A Monn, J Li, et al.
Nature|December 2, 1999
Kainate receptors are involved in synaptic plasticityZ A Bortolotto, V R Clarke, C M Delany, et al.
Nature|October 23, 1997
A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmissionV R Clarke, B A Ballyk, K H Hoo, et al.
Journal of Medicinal Chemistry|November 23, 2000
Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic acid (AMPA) receptorsP L Ornstein, D M Zimmerman, M B Arnold, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivativesMatthew J Fisher, Ryan T Backer, Iván Collado, et al.
Neuropharmacology|January 10, 2016
In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu<sub>2/3</sub> receptor antagonistJeffrey M Witkin, Paul L Ornstein, Charles H Mitch, et al.
Pageof 24

Showing results (211-220 of 233) with videos related to

Sort By:
Pageof 24
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivoA Bond, N M Jones, C A Hicks, et al.
Journal of Medicinal Chemistry|July 21, 1998
Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonistsH Zarrinmayeh, A M Nunes, P L Ornstein, et al.
Cephalalgia : an International Journal of Headache|June 16, 2004
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineC N Sang, N M Ramadan, R G Wallihan, et al.
Nature Neuroscience|June 25, 2002
Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizuresIlse Smolders, Zuner A Bortolotto, Vernon R J Clarke, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2017
Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effectsJ M Witkin, J A Monn, J Li, et al.
Nature|December 2, 1999
Kainate receptors are involved in synaptic plasticityZ A Bortolotto, V R Clarke, C M Delany, et al.
Nature|October 23, 1997
A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmissionV R Clarke, B A Ballyk, K H Hoo, et al.
Journal of Medicinal Chemistry|November 23, 2000
Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic acid (AMPA) receptorsP L Ornstein, D M Zimmerman, M B Arnold, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivativesMatthew J Fisher, Ryan T Backer, Iván Collado, et al.
Neuropharmacology|January 10, 2016
In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu<sub>2/3</sub> receptor antagonistJeffrey M Witkin, Paul L Ornstein, Charles H Mitch, et al.
Pageof 24